Zobrazeno 1 - 10 of 411 pro vyhledávání: '"Achkova D"'
1
Akademický článek
Intratumoral pan-ErbB targeted CAR-T for head and neck squamous cell carcinoma: interim analysis of the T4 immunotherapy study.
Autor: Papa S; School of Cancer & Pharmaceutical Sciences, King's College London, London, UK.; Department of Medical Oncology, Guy's and St Thomas' NHS Foundation Trust, London, UK., Adami A; School of Cancer & Pharmaceutical Sciences, King's College London, London, UK., Metoudi M; School of Cancer & Pharmaceutical Sciences, King's College London, London, UK., Beatson R; School of Cancer & Pharmaceutical Sciences, King's College London, London, UK., George MS; Department of Infectious Diseases, School of Immunology & Microbial Sciences, King's College London, London, UK., Achkova D; School of Cancer & Pharmaceutical Sciences, King's College London, London, UK., Williams E; Department of Immunobiology, School of Immunology & Microbial Sciences, King's College London, London, UK., Arif S; Department of Immunobiology, School of Immunology & Microbial Sciences, King's College London, London, UK., Reid F; School of Life Course & Population Sciences, King's College London, London, UK., Elstad M; School of Life Course & Population Sciences, King's College London, London, UK., Beckley-Hoelscher N; Department of Biostatistics and Health Informatics, Institute of Psychiatry Psychology & Neuroscience, King's College London, London, UK., Douri A; School of Life Course & Population Sciences, King's College London, London, UK., Delord M; School of Life Course & Population Sciences, King's College London, London, UK., Lyne M; Guy's and St Thomas' Biomedical Research Centre, Guy's and St Thomas' NHS Foundation Trust and King's College London, London, UK., Shivapatham D; Guy's and St Thomas' Biomedical Research Centre, Guy's and St Thomas' NHS Foundation Trust and King's College London, London, UK., Fisher C; Good Manufacturing Practice Unit, Guy's and St Thomas' Biomedical Research Centre, Guy's and St Thomas' NHS Foundation Trust, London, UK., Hope A; Good Manufacturing Practice Unit, Guy's and St Thomas' Biomedical Research Centre, Guy's and St Thomas' NHS Foundation Trust, London, UK., Gooljar S; Good Manufacturing Practice Unit, Guy's and St Thomas' Biomedical Research Centre, Guy's and St Thomas' NHS Foundation Trust, London, UK., Mitra A; Good Manufacturing Practice Unit, Guy's and St Thomas' Biomedical Research Centre, Guy's and St Thomas' NHS Foundation Trust, London, UK., Gomm L; Guy's and St Thomas' Biomedical Research Centre, Guy's and St Thomas' NHS Foundation Trust and King's College London, London, UK., Morton C; Department of Medical Oncology, Guy's and St Thomas' NHS Foundation Trust, London, UK.; Guy's and St Thomas' Biomedical Research Centre, Guy's and St Thomas' NHS Foundation Trust and King's College London, London, UK., Henley-Smith R; Head and Neck Pathology, Guy's and St Thomas' NHS Foundation Trust, London, UK., Thavaraj S; Head and Neck Pathology, Guy's and St Thomas' NHS Foundation Trust, London, UK.; Faculty of Dentistry, Oral and Craniofacial Sciences, Guy's Hospital, King's College London, London, UK., Santambrogio A; Faculty of Dentistry, Oral and Craniofacial Sciences, Guy's Hospital, King's College London, London, UK., Andoniadou C; Faculty of Dentistry, Oral and Craniofacial Sciences, Guy's Hospital, King's College London, London, UK., Allen S; Department of Nuclear Medicine, Guy's and St Thomas' NHS Foundation Trust, London, UK., Gibson V; Department of Nuclear Medicine, Guy's and St Thomas' NHS Foundation Trust, London, UK., Cook GJR; London School of Biomedical Engineering and Imaging Sciences, King's College London, London, UK., Parente-Pereira AC; School of Cancer & Pharmaceutical Sciences, King's College London, London, UK., Davies DM; School of Cancer & Pharmaceutical Sciences, King's College London, London, UK., Farzaneh F; School of Cancer & Pharmaceutical Sciences, King's College London, London, UK., Schurich A; Department of Infectious Diseases, School of Immunology & Microbial Sciences, King's College London, London, UK., Guerrero-Urbano T; Department of Head and Neck Oncology, Guy's and St Thomas' NHS Foundation Trust, London, UK., Jeannon JP; Department of Head and Neck Oncology, Guy's and St Thomas' NHS Foundation Trust, London, UK., Spicer J; School of Cancer & Pharmaceutical Sciences, King's College London, London, UK.; Department of Medical Oncology, Guy's and St Thomas' NHS Foundation Trust, London, UK., Maher J; School of Cancer & Pharmaceutical Sciences, King's College London, London, UK john.maher@kcl.ac.uk.; Department of Immunology, Eastbourne Hospital, Eastbourne, UK.; Leucid Bio Ltd, London, London, UK.
Publikováno v: Journal for immunotherapy of cancer [J Immunother Cancer] 2023 Jun; Vol. 11 (6).
Zobrazit plný text záznamu
2
Role of interleukin-35 in sublingual allergy immunotherapy
Autor: Shamji, MH, Layhadi, JA, Achkova, D, Kouser, L, Perera-Webb, A, Couto-Francisco, NC, Parkin, R, Matsuoka, T, Scadding, G, Ashton-Rickardt, PG, Durham, SR
Publikováno v: 1142.e4
BACKGROUND: Grass pollen-specific immunotherapy involves immunomodulation of allergen-specific T helper 2 cell (Th2) responses and induction of IL-10+ and/or TGF-β+CD4+CD25+ regulatory T cells (iTregs). IL-35+CD4+CD25+Foxp3- T (iTR35) cells have bee
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=od______1032::9e1a84bbb3ac0764409ee19a6537f420
http://hdl.handle.net/10044/1/61503
Zobrazit plný text záznamu
3
Akademický článek
TGF-β1 potentiates Vγ9Vδ2 T cell adoptive immunotherapy of cancer.
Autor: Beatson RE; King's College London, School of Cancer and Pharmaceutical Sciences, Guy's Cancer Centre, Great Maze Pond, London SE1 9RT, UK., Parente-Pereira AC; King's College London, School of Cancer and Pharmaceutical Sciences, Guy's Cancer Centre, Great Maze Pond, London SE1 9RT, UK., Halim L; King's College London, School of Cancer and Pharmaceutical Sciences, Guy's Cancer Centre, Great Maze Pond, London SE1 9RT, UK., Cozzetto D; Translational Bioinformatics, NIHR Biomedical Research Centre, Guy's and St. Thomas's NHS Foundation Trust and King's College London, London SE1 9RT, UK., Hull C; King's College London, School of Cancer and Pharmaceutical Sciences, Guy's Cancer Centre, Great Maze Pond, London SE1 9RT, UK., Whilding LM; King's College London, School of Cancer and Pharmaceutical Sciences, Guy's Cancer Centre, Great Maze Pond, London SE1 9RT, UK., Martinez O; King's College London, School of Cancer and Pharmaceutical Sciences, Guy's Cancer Centre, Great Maze Pond, London SE1 9RT, UK., Taylor CA; King's College London, School of Cancer and Pharmaceutical Sciences, Guy's Cancer Centre, Great Maze Pond, London SE1 9RT, UK., Obajdin J; King's College London, School of Cancer and Pharmaceutical Sciences, Guy's Cancer Centre, Great Maze Pond, London SE1 9RT, UK., Luu Hoang KN; King's College London, School of Cancer and Pharmaceutical Sciences, Guy's Cancer Centre, Great Maze Pond, London SE1 9RT, UK., Draper B; King's College London, School of Cancer and Pharmaceutical Sciences, Guy's Cancer Centre, Great Maze Pond, London SE1 9RT, UK., Iqbal A; King's College London, School of Cancer and Pharmaceutical Sciences, Guy's Cancer Centre, Great Maze Pond, London SE1 9RT, UK.; Cancer Bioinformatics, King's College London, School of Cancer and Pharmaceutical Sciences, Guy's Cancer Centre, Great Maze Pond, London SE1 9RT, UK., Hardiman T; King's College London, School of Cancer and Pharmaceutical Sciences, Guy's Cancer Centre, Great Maze Pond, London SE1 9RT, UK.; Cancer Bioinformatics, King's College London, School of Cancer and Pharmaceutical Sciences, Guy's Cancer Centre, Great Maze Pond, London SE1 9RT, UK., Zabinski T; King's College London, School of Cancer and Pharmaceutical Sciences, Guy's Cancer Centre, Great Maze Pond, London SE1 9RT, UK., Man F; King's College London, School of Biomedical Engineering and Imaging Sciences, St. Thomas' Hospital, London SE1 7EH, UK., de Rosales RTM; King's College London, School of Biomedical Engineering and Imaging Sciences, St. Thomas' Hospital, London SE1 7EH, UK., Xie J; Bayer Healthcare Innovation Center, Mission Bay, 455 Mission Bay Boulevard South, San Francisco, CA 94158, USA., Aswad F; Bayer Healthcare Innovation Center, Mission Bay, 455 Mission Bay Boulevard South, San Francisco, CA 94158, USA., Achkova D; King's College London, School of Cancer and Pharmaceutical Sciences, Guy's Cancer Centre, Great Maze Pond, London SE1 9RT, UK., Joseph CR; King's College London, School of Cancer and Pharmaceutical Sciences, Guy's Cancer Centre, Great Maze Pond, London SE1 9RT, UK., Ciprut S; King's College London, School of Cancer and Pharmaceutical Sciences, Guy's Cancer Centre, Great Maze Pond, London SE1 9RT, UK., Adami A; King's College London, School of Cancer and Pharmaceutical Sciences, Guy's Cancer Centre, Great Maze Pond, London SE1 9RT, UK., Roider HG; Bayer AG, Müllerstrasse 178, 13342 Berlin, Germany., Hess-Stumpp H; Bayer AG, Müllerstrasse 178, 13342 Berlin, Germany., Győrffy B; Department of Bioinformatics, Semmelweis University, Budapest H1085, Hungary.; Cancer Biomarker Research Group, Research Center for Natural Science, Budapest H1117, Hungary., Quist J; King's College London, School of Cancer and Pharmaceutical Sciences, Guy's Cancer Centre, Great Maze Pond, London SE1 9RT, UK.; Cancer Bioinformatics, King's College London, School of Cancer and Pharmaceutical Sciences, Guy's Cancer Centre, Great Maze Pond, London SE1 9RT, UK., Grigoriadis A; King's College London, School of Cancer and Pharmaceutical Sciences, Guy's Cancer Centre, Great Maze Pond, London SE1 9RT, UK.; Cancer Bioinformatics, King's College London, School of Cancer and Pharmaceutical Sciences, Guy's Cancer Centre, Great Maze Pond, London SE1 9RT, UK., Sommer A; Bayer AG, Müllerstrasse 178, 13342 Berlin, Germany., Tutt ANJ; King's College London, Breast Cancer Now Unit, School of Cancer and Pharmaceutical Sciences, Guy's Cancer Centre, Great Maze Pond, London SE1 9RT, UK., Davies DM; King's College London, School of Cancer and Pharmaceutical Sciences, Guy's Cancer Centre, Great Maze Pond, London SE1 9RT, UK., Maher J; King's College London, School of Cancer and Pharmaceutical Sciences, Guy's Cancer Centre, Great Maze Pond, London SE1 9RT, UK.; Department of Immunology, Eastbourne Hospital, Kings Drive, Eastbourne, East Sussex BN21 2UD, UK.; Department of Clinical Immunology and Allergy, King's College Hospital NHS Foundation Trust, Denmark Hill, London SE5 9RS, UK.; Leucid Bio, Guy's Hospital, Great Maze Pond, London SE1 9RT, UK.
Publikováno v: Cell reports. Medicine [Cell Rep Med] 2021 Dec 21; Vol. 2 (12), pp. 100473. Date of Electronic Publication: 2021 Dec 21 (Print Publication: 2021).
Zobrazit plný text záznamu
4
Akademický článek
O-linked mucin-type glycosylation regulates the transcriptional programme downstream of EGFR.
Autor: Tajadura-Ortega V; Breast Cancer Biology Lab, School of Cancer & Pharmaceutical Sciences, King's College London, London SE1 9RT, UK.; Glycosciences Laboratory, Department of Metabolism, Digestion and Reproduction, Imperial College London, Burlington Danes Building, Du Cane Road, London W12 0NN, UK., Gambardella G; Department of Chemical Materials and Industrial Engineering, University of Naples Federico II, 1-80125 Naples, Italy.; Telethon Institute of Genetics and Medicine (TIGEM), 80078 Pozzuoli, Italy., Skinner A; Breast Cancer Biology Lab, School of Cancer & Pharmaceutical Sciences, King's College London, London SE1 9RT, UK., Halim A; Functional and Cellular Glycobiology, Glycomics Programme, University of Copenhagen, Copenhagen DK-2200, Denmark., Van Coillie J; Functional and Cellular Glycobiology, Glycomics Programme, University of Copenhagen, Copenhagen DK-2200, Denmark., Schjoldager KTG; Functional and Cellular Glycobiology, Glycomics Programme, University of Copenhagen, Copenhagen DK-2200, Denmark., Beatson R; Breast Cancer Biology Lab, School of Cancer & Pharmaceutical Sciences, King's College London, London SE1 9RT, UK., Graham R; Breast Cancer Biology Lab, School of Cancer & Pharmaceutical Sciences, King's College London, London SE1 9RT, UK., Achkova D; CAR Mechanics Lab, School of Cancer & Pharmaceutical Sciences, King's College London, London SE1 9RT, UK.; Autolus Ltd. Forest House, 58 Wood Ln, White City, London W12 7RZ, UK., Taylor-Papadimitriou J; Breast Cancer Biology Lab, School of Cancer & Pharmaceutical Sciences, King's College London, London SE1 9RT, UK., Ciccarelli FD; Cancer Systems Biology Laboratory, Francis Crick Institute, London NW1 1AT, UK.; CRUK King's Health Partner Centre, King's College London, London SE1 9RT, UK., Burchell JM; Breast Cancer Biology Lab, School of Cancer & Pharmaceutical Sciences, King's College London, London SE1 9RT, UK.
Publikováno v: Glycobiology [Glycobiology] 2021 Apr 01; Vol. 31 (3), pp. 200-210.
Zobrazit plný text záznamu
5
Akademický článek
PTPN11 is a potential biomarker for type 2 diabetes mellitus complicated with colorectal cancer.
Autor: Sun, Meiling1 (AUTHOR), Han, Zhe2,3 (AUTHOR), Luo, Zhimin4 (AUTHOR), Ge, Lijuan5 (AUTHOR), Zhang, Xiaolin6 (AUTHOR), Feng, Keshu2,3 (AUTHOR), Zhang, Guoshan6 (AUTHOR), Xu, Fuyi2,3 (AUTHOR), Zhou, Hongpan1 (AUTHOR), Han, Hailin1 (AUTHOR), Jiang, Wenguo2,3 (AUTHOR) jiangwg@bzmc.edu.cn
Publikováno v: Scientific Reports. 10/24/2024, Vol. 14 Issue 1, p1-17. 17p.
Zobrazit plný text záznamu
6
Akademický článek
Contemporaneous Inflammatory, Angiogenic, Fibrogenic, and Angiostatic Cytokine Profiles of the Time-to-Tumor Development by Cancer Cells to Orchestrate Tumor Neovascularization, Progression, and Metastasis.
Autor: Skapinker, Elizabeth1 (AUTHOR) 21ess18@queensu.ca, Aucoin, Emilyn B.2 (AUTHOR) emilynaucoin@gmail.com, Kombargi, Haley L.3 (AUTHOR) 20hlk@queensu.ca, Yaish, Abdulrahman M.3 (AUTHOR) a.yaish@queensu.ca, Li, Yunfan1 (AUTHOR) 18yl210@queensu.ca, Baghaie, Leili4 (AUTHOR) 16lbn1@queensu.ca, Szewczuk, Myron R.4 (AUTHOR) szewczuk@queensu.ca
Publikováno v: Cells (2073-4409). Oct2024, Vol. 13 Issue 20, p1739. 26p.
Zobrazit plný text záznamu
8
Akademický článek
Single cell RNA-Sequencing Reveals Mast Cells Enhance Mononuclear Phagocytes Infiltration in Bladder Cancer Microenvironment.
Autor: Zige Liu1,2, Caisheng Huang1,2,3, Xingning Mao2, Junhao Mi2, Qingyun Zhang2,4, Yuli Xie2,5, Hao Yuan2,5, Mujia Jili2,5, Jiange Zhang2,6, Jianxin Chen1,2,4, Shengzhu Huang2, Zengnan Mo1,2 mozengnan@gxmu.edu.cn, Rirong Yang2,5 520yrr@163.com
Publikováno v: Journal of Cancer. 2024, Vol. 15 Issue 17, p5672-5690. 19p.
Zobrazit plný text záznamu
9
Akademický článek
Insights into the Gene Expression Profile of Classical Hodgkin Lymphoma: A Study towards Discovery of Novel Therapeutic Targets.
Autor: Aloliqi, Abdulaziz A.1 (AUTHOR) aaalieky@qu.edu.sa
Publikováno v: Molecules. Aug2024, Vol. 29 Issue 15, p3476. 28p.
Zobrazit plný text záznamu
10
Akademický článek
Infusion and delivery strategies to maximize the efficacy of CAR-T cell immunotherapy for cancers.
Autor: Gu, Xinyu1 (AUTHOR), Zhang, Yalan1 (AUTHOR), Zhou, Weilin1 (AUTHOR), Wang, Fengling1 (AUTHOR), Yan, Feiyang1 (AUTHOR), Gao, Haozhan1 (AUTHOR), Wang, Wei1 (AUTHOR) weiwang@scu.edu.cn
Publikováno v: Experimental Hematology & Oncology. 7/26/2024, Vol. 13 Issue 1, p1-17. 17p.
Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje